A Randomised, Double Blind, Placebo-controlled, Multicenter Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Lersivirine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 17 Oct 2013 Additional lead trial centre added as reported by ClinicalTrials.gov record.
- 23 Oct 2009 Results were reported in AIDS.
- 29 Oct 2006 New trial record.